Evidence map›Paper›PMID 39488529›Full record

ArticleNature communications2024

Live imaging of airway epithelium reveals that mucociliary clearance modulates SARS-CoV-2 spread.

Mark E Becker, Laura Martin-Sancho, Lacy M Simons, Michael D McRaven, Sumit K Chanda, Judd F Hultquist, Thomas J Hope

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Mucins and Respiratory Virus Infection.Annual review of virology · 2026
    Review
  3. Article
  4. The triple-hit hypothesis: exploring pulmonary e-cigarette, PMEuropean respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Intrinsic OASL expression governs heterogeneity in interferon induction during influenza A virus infection.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Frontiers in cellular and infection microbiology · 2025
    Review
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Mark E BeckerDepartment of Cell & Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.ORCID 0000-0002-5992-2806
Laura Martin-SanchoDepartment of Infectious Diseases, Imperial College London, London, UK.
Lacy M SimonsDivision of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.ORCID 0000-0003-4041-6775
Michael D McRavenDepartment of Cell & Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Sumit K ChandaDepartment of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA, USA.ORCID 0000-0001-9399-7927
Judd F HultquistDivision of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.ORCID 0000-0001-6424-4280
Thomas J HopeDepartment of Cell & Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. thope@northwestern.edu.ORCID 0000-0001-7183-8319

Funding

Project 3 - Ex vivo immune profiling of dengue viruses and vaccinesU19AI118610 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KASARSKIS, ANDREW · 2015 to 2021
$46.6M
SARS-CoV adaptations through a Systems Biology Lens (SYBIL)U19AI135972 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Adolfo Garcia-Sastre · 2018 to 2026
$27.2M
Technology CoreU19AI135964 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI RICHARD G WUNDERINK · 2018 to 2026
$24.7M
Identification of the Initial Targets of Transmission R37AI094595 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Thomas Hope · 2017 to 2026
$10.0M
Identification of the Initial Targets of TransmissionR01AI094595 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HOPE, THOMAS · 2011 to 2015
$4.5M
Viral and Host Dynamics during Pediatric COVID-19 and Respiratory Virus Co-InfectionR01AI177498 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Bria M Coates, Judd F Hultquist · 2024 to 2026
$2.4M
Assessing the Risk of SARS-CoV-2 Remdesivir ResistanceR21AI163912 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HULTQUIST, JUDD F · 2021 to 2022
$440k
NIAID NIH HHS R01 AI094595NIAID NIH HHS R01 AI177498NIAID NIH HHS R21 AI163912NIAID NIH HHS R37 AI094595NIAID NIH HHS U19 AI118610NIAID NIH HHS U19 AI135964NIAID NIH HHS U19 AI135972U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI094595-09S1U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI118610U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI135964U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI135972
6 · The paper itself

Abstract

SARS-CoV-2 initiates infection in the conducting airways, where mucociliary clearance inhibits pathogen penetration. However, it is unclear how mucociliary clearance impacts SARS-CoV-2 spread after infection is established. To investigate viral spread at this site, we perform live imaging of SARS-CoV-2 infected differentiated primary human bronchial epithelium cultures for up to 12 days. Using a fluorescent reporter virus and markers for cilia and mucus, we longitudinally monitor mucus motion, ciliary motion, and infection. Infected cell numbers peak at 4 days post infection, forming characteristic foci that tracked mucus movement. Inhibition of MCC using physical and genetic perturbations limits foci. Later in infection, mucociliary clearance deteriorates. Increased mucus secretion accompanies ciliary motion defects, but mucociliary clearance and vectorial infection spread resume after mucus removal, suggesting that mucus secretion may mediate MCC deterioration. Our work shows that while MCC can facilitate SARS-CoV-2 spread after initial infection, subsequent MCC decreases inhibit spread, revealing a complex interplay between SARS-CoV-2 and MCC.

Indexed as

CiliaCOVID-19Mucociliary ClearanceSARS-CoV-2BronchiCells, CulturedEpithelial CellsHumansMucusRespiratory Mucosa

Identifiers

PMID39488529
PMCPMC11531594

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.